Medplus Health Services Limited
MedPlus subsidiary Optival Health Solutions received two drug license suspension orders in Karnataka. The suspensions, for 4 and 5 days, could lead to a total revenue loss of ₹4.98 lakhs.
Apr 17 2026 17:04:00
Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
MedPlus Health's subsidiary Optival Health Solutions received two drug license suspension orders, leading to a potential revenue loss of ₹6.81 lacs. The orders were issued by drug control authorities in Andhra Pradesh and Odisha for rule violations.
Apr 15 2026 17:04:00
Medplus Health Services Limited
MedPlus Health Services' subsidiary, Optival Health Solutions, received two drug license suspension orders for its stores in Eluru and Bhubaneswar. These orders could result in a total potential revenue loss of ₹6.81 lakhs due to violations of the Drugs and Cosmetics Act.
Apr 15 2026 17:04:00
Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Optival Health Solutions Private Limited, a subsidiary of MedPlus, received a five-day drug license suspension for a store in Odisha. This regulatory action, which was received on April 10, 2026, carries a potential revenue loss of ₹3.80 lakhs.
Apr 11 2026 12:04:00
Medplus Health Services Limited
MedPlus Health Services' subsidiary, Optival Health Solutions, received a 5-day drug license suspension for a drug license in Odisha. This action by the Dy. Drugs Controller is expected to result in a potential revenue loss of ₹3.80 lakhs for the company.
Apr 11 2026 12:04:00
Medplus Health Services Limited
MedPlus subsidiary Optival Health Solutions' drug license was suspended for two days for a store in Jadcherla, Telangana, on April 08, 2026. This regulatory action carries a minimal potential revenue loss of ₹0.28 lacs.
Apr 09 2026 18:04:00
Medplus Health Services Limited
MedPlus subsidiary Optival Health Solutions faced a 2-day drug license suspension for a store in Telangana. The incident could result in a potential revenue loss of ₹0.16 lakhs and was issued by the Assistant Director, Drugs Control Administration.
Apr 03 2026 16:04:00
Medplus Health Services Limited
MedPlus's subsidiary, Optival Health Solutions, received a three-day drug license suspension for one of its stores in Warangal, Telangana. This regulatory action carries a potential revenue loss of ₹0.60 lakhs.
Mar 29 2026 17:03:00
Medplus Health Services Limited
Medplus Health Services board will convene on May 29, 2026, to approve the standalone and cons. financial results for the full fiscal year 2026. This meeting is crucial for reviewing the company's annual performance.
Mar 28 2026 17:03:00
Medplus Health Services Ltd - 543427 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI LODR ")
MedPlus Health Services Board to meet on May 29, 2026, to approve the audited standalone and cons. financial results for Q4 FY26 and the full financial year. This meeting will finalize the company's financial performance for the period.
Mar 28 2026 17:03:00
Read More